Federal contract award
HHSO100201700013C
IGF::OT::IGF
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541711 |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $132.3M |
| Current contract value | $132.3M |
| Potential contract value / ceiling | $196.4M |
| Start date | Sep 28, 2017 |
| Current end date | Mar 30, 2026 |
| Potential end date | Mar 30, 2026 |
| Latest award activity | Jan 22, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jan 22, 2025 | P00009 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO UPDATE THE KEY PERSONNEL UNDER SECTION G CONTRACT ADMINISTRATION ARTICLE G.4 KEY PERSONNEL TO INCLUDE JOHNNIE LEAD AS CLINICAL LEAD. |
| Oct 8, 2024 | P00008 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO UPDATE THE STATEMENT OF WORK TO PROVIDE ADDITIONAL INFORMATION |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.